NYU Langone
J

Common TKI Toxicity Management in 2L HCC Treatment

By NYU Langone FEATURING Jennifer Wu
By NYU Langone FEATURING Jennifer Wu
415 views
May 4, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Recommended

Houston Methodist

Inaugural Houston Methodist Neal Cancer Center GI Oncology Symposium

Fri, Dec 6, 2024
17:12

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

1.5K views

·

2 months ago
57:44

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

5.1K views

·

1 year ago
15:19

Current Recommendations on Managing GI Adverse Reactions Associated …

Alberto Zambelli

946 views

·

4 months ago
26:06

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

608 views

·

1 month ago
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

·

7 months ago
18:21

New

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

375 views

·

3 weeks ago
20:09

ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunot…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

371 views

·

2 months ago
05:59

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

306 views

·

1 month ago
10:57

Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

632 views

·

8 months ago
20:41

Managing Dermatologic Toxicities: Cutaneous irAEs Associated with Im…

Cleveland Clinic Taussig Cancer Institute

R. Unwala

273 views

·

1 month ago
13:05

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

195 views

·

1 month ago
14:27

Infectious Complications of Checkpoint Inhibitors: Discussing Overla…

Cleveland Clinic Taussig Cancer Institute

Z. Yetmar

209 views

·

1 month ago
15:30

Updates in Combination Therapy for HCC

Yale Cancer Center

S. Stein

456 views

·

6 months ago
53:42

Managing Women's Health in Menopause: Evolving Approaches for the Ma…

PleXus Communications

J. Simon, T. Iyer, A. Fiffick, M. Minkin

2.8K views

·

1 year ago
04:39

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

196 views

·

1 month ago
25:09

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

375 views

·

5 months ago
26:59

2023 AASLD Guidance for HCC

University of Texas Southwestern Medical Center

A. Singal

815 views

·

1 year ago
20:13

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

206 views

·

1 month ago
16:40

Year in Review: Hepatobiliary Cancers

Moffitt Cancer Center

R. Kim, T. Biachi

604 views

·

10 months ago
09:56

ESMO 2024 Insights: HIMALAYA - 5-Year OS of Tremelimumab + Durvaluma…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

168 views

·

2 months ago
AUTOPLAY